DuPont de Nemours, Inc. (DD) Business Profile

What it does

DuPont de Nemours sells materials, components and technologies used in healthcare, water treatment, construction and industrial manufacturing. Founded in 2015 and headquartered in Wilmington, the company is led by Chief Executive Officer Lori Koch.

Its Healthcare & Water Technologies segment supplies medical packaging, protective garments and components for medical devices, as well as technologies that filter and purify water. Its customers use these products in applications ranging from packaging medical equipment to treating industrial wastewater and producing drinking water.

Its Diversified Industrials segment sells building materials and industrial technologies. Building products include Tyvek house wrap, Styrofoam insulation and Corian solid surfaces. Industrial products include adhesives, lubricants, engineered parts and printing plates used in markets such as aerospace, automotive and packaging.

DuPont also provides product design, prototyping and manufacturing services for healthcare customers. Its water business sells filtration elements, modules and systems, while its industrial business designs components and process solutions for manufacturers and other industrial users.

The company separated its semiconductor and interconnect solutions businesses into Qnity Electronics on November 1, 2025. DuPont’s continuing businesses are organized into its healthcare and water and diversified industrials segments.

How it makes money

DuPont earns revenue by selling products and services through two reportable segments. Healthcare & Water Technologies supplies medical packaging, protective garments and medical device components, alongside water filtration and separation products. Diversified Industrials sells building materials and industrial products such as engineered parts, structural adhesives, specialty lubricants and printing plates.

Healthcare customers can buy materials and components as well as design, prototyping and manufacturing services. In water, customers buy elements, modules and systems for uses including wastewater treatment, municipal drinking water, desalination and life sciences. In construction, DuPont sells products used across the building envelope and interior, from insulation and house wrap to solid surfaces.

The company sells most products through its own sales organization, with distributors emphasized more heavily for some lines. Its industrial offerings also include components and process solutions used in manufacturers’ equipment and operations. The available disclosures do not specify a subscription or other recurring-revenue model for these products.

DuPont takes pricing actions to offset higher energy and raw material costs, although its success depends on competitive and economic conditions in each market. The company expects pricing actions already taken to fully offset higher input costs in 2026.

In the third quarter of 2026, net sales were $1.9 billion, including $865 million from Healthcare & Water Technologies and $1 billion from Diversified Industrials. DuPont uses Operating EBITDA to assess segment performance and allocate resources; certain corporate and shared-service costs associated with separated businesses remain in continuing operations.

Customers and how it sells

DuPont serves medical device and biopharmaceutical companies, water utilities and industrial water users, builders, and manufacturers in aerospace, automotive, printing and packaging. Its construction products serve residential and non-residential new builds as well as repair and remodeling projects.

The company markets most products through its own sales organization. Its distribution network also includes distributors, independent retailers, cooperatives and agents. DuPont provides technical and testing services and develops products around customers’ technological and regulatory requirements.

At December 31, 2025, DuPont had subsidiaries in about 50 countries worldwide and manufacturing operations in about 20 countries. It employed approximately 15,000 people worldwide at that date, including approximately 1,700 dedicated to the Aramids business.

DuPont says its automotive exposure in China is more concentrated among multinational manufacturers than local manufacturers. It also has orders for large water projects in the Middle East, although continuing disruptions have pushed those projects into 2027.

Suppliers and costs

DuPont uses a wide variety of raw materials to manufacture its products and requires a continuing supply of energy. It also relies on third-party suppliers, contract manufacturers and service providers across supply chains that extend through multiple countries.

Raw material and energy prices are driven by global supply and demand. Supply chain disruptions and inflation have affected raw material prices and availability. DuPont generally seeks multiple sources for key raw materials; where supply markets are concentrated, it also uses measures such as negotiated long-term contracts, some with minimum purchase obligations.

The company operates manufacturing facilities in about 20 countries. Its costs also include corporate overhead and shared services. Some indirect costs previously allocated to separated or divested businesses remain in continuing operations, including costs that are not subject to future reimbursement.

Research and development sits within the individual businesses rather than a centralized organization. DuPont spends about 2.5% of sales in total on research and development, allocating spending among its businesses.

Competitive position

DuPont competes with multinational companies and established regional companies across its markets. Competition involves product innovation, technology, pricing, customer service, sustainability practices and changing regulation. No competitor is identified by name as competing with DuPont in the available descriptions.

The company provides technical support and testing services alongside its products. It develops offerings for customers’ industry-specific technological and regulatory needs, and its healthcare and water business uses application development expertise and specialized manufacturing in regulated applications.

Our reading: Application expertise and customer support can help DuPont compete where products must meet particular performance and regulatory requirements, although their strength can differ by application.

DuPont also owns or licenses patents and trademarks and keeps many manufacturing processes as trade secrets. Its brands include Tyvek in medical packaging and construction, FilmTec in water treatment, and Vespel in industrial components.

Our reading: Intellectual property and recognized brands can support differentiation, but their protection varies by product and jurisdiction. The presence of multinational and regional competitors also means those advantages do not remove pricing and innovation pressure.

Growth opportunities

DuPont expects growth in healthcare from medical packaging and medical devices, and in water from demand for reverse osmosis and ion exchange in industrial and municipal markets. It also expects industrial growth to be supported by aerospace and recovery in markets served by its industrial product lines.

The company has added capabilities through acquisitions. Donatelle designs, develops and manufactures medical components and devices, while Sinochem manufactures reverse osmosis products in China. Both are part of Healthcare & Water Technologies. DuPont also acquired Spectrum, a manufacturer of medical devices and components.

More recently, DuPont expanded its bioprocessing portfolio with purification technology for peptide therapeutics, including GLP-1 drugs. It launched Tyvek with renewable attribution and secured an automotive customer win for Betatech thermal material used in batteries. It also received a containerized desalination project using its ultrafiltration modules in Europe, the Middle East and Africa.

For full-year 2026, DuPont expects organic sales growth of approximately 4.5% and sales of about $7.19 billion. Its outlook assumes large Middle East water projects for which it has orders will be pushed into 2027 because of continuing disruptions. DuPont also says it is investing in product innovation, sales processes and productivity across its businesses.

Structural risks

• Legacy environmental liabilities: DuPont shares certain liabilities related to past businesses, including PFAS liabilities. Environmental remediation estimates are uncertain, and potential liabilities under adverse changes in circumstances may be materially higher than accruals.
• Indemnification and counterparty obligations: DuPont has assumed or agreed to indemnify others for certain liabilities. Parties responsible for indemnifying DuPont may be unable to satisfy their obligations, leaving DuPont to bear losses temporarily or permanently.
• Separation-related taxes: If the Qnity distribution or certain related transactions fail to qualify for their intended tax treatment, DuPont could incur significant tax liabilities. Other past separations and divestitures also carry tax-related risks.
• Supply and input costs: Disruptions affecting suppliers, contract manufacturers or DuPont’s operations could raise costs and affect sales. Energy and raw material prices can be volatile, and competitive conditions can limit DuPont’s ability to offset increases through pricing.
• Litigation and regulation: DuPont faces product liability, intellectual property, commercial, personal injury and other claims. Its manufacturing and distribution facilities are also subject to environmental laws and regulations.

Bottom line

Our reading

Our reading: DuPont is a specialty materials and technologies business whose products serve different customers but often depend on application expertise, manufacturing and technical support. Its healthcare and water portfolio offers routes to growth alongside construction and industrial markets. Its exposure includes input-cost volatility and competition, while liabilities and tax obligations connected to past businesses and separations remain important risks.